XENE
Xenon Pharmaceuticals Inc.
Latest News for XENE
In a report released on May 8, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Xenon, with a price target of $86.00. The company’s sha......
Wells Fargo analyst Benjamin Burnett maintained a Buy rating on Xenon on May 8 and set a price target of $69.00. The company’s shares closed last F......
Evercore ISI analyst Cory Kasimov maintained a Buy rating on Xenon today and set a price target of $80.00. Kasimov covers the Healthcare sector, fo......
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Xenon today and set a price target of $74.00. Tsao covers the Healthcare sector, fo......
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Xenon today and set a price target of $74.00. Tsao covers the Healthcare sector, fo......
Xenon ( ($XENE) ) just unveiled an update. Xenon Pharmaceuticals reported first-quarter 2026 results on May 7, highlighting positive Phase 3 X-TOLE......
In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Xenon, with a price target of $89.00. Matteis covers the H......
News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XENE | $53.98 | -0.4% | 1.83M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Xenon Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW